Pictet Asset Management Holding SA »

Amicus Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $80M 6.8M 11.80

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
BlackRock
Jpmorgan Chase & Co
Wellington Management Company
Henderson Group
Redmile Group
William Blair Investment Management
Morgan Stanley
Palo Alto Investors
Pictet Asset Management Holding SA
Geode Capital Management
Fiera Capital Corporation
American Century Companies

View all funds holding Amicus Therapeutics